Source link : https://www.newshealth.biz/health-news/renewed-hope-in-advanced-anal-cancer-with-ici-chemo-combo/
BARCELONA, Spain — Adding retifanlimab, an anti–programmed cell death 1 (PD-1) monoclonal antibody, to carboplatin plus paclitaxel in inoperable locally recurrent or metastatic squamous cell carcinoma (SCC) of the anal canal markedly improves survival outcomes, findings from the POD1UM-303 trial showed. The research, presented at the European Society for Medical Oncology (ESMO) Annual Meeting 2024, […]
Author : News Health
Publish date : 2024-09-16 10:45:11
Copyright for syndicated content belongs to the linked Source.